Sponsor content
84 result(s) found, displaying 11 to 20
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Heparin INTERPHARMA heparin sodium 5000 IU in 0.5 mL solution for injection pre-filled syringe.
-
Australian public assessment report (AusPar)Heparin InterPharma (heparin sodium) has been approved for the prophylaxis and treatment of deep vein thrombosis in patients 18 years and older.
-
Cancellation or suspensionThe devices were Suspended under section 41GA of the Act, and the period of suspension of the Device from the ARTG has expired. Therefore, the suspended ARTG must be cancelled as per section 41GK of the Act, effective 21/06/2024
-
Cancellation or suspensionThe devices were Suspended under section 41GA of the Act, and the period of suspension of the Device from the ARTG has expired. Therefore, the suspended ARTG must be cancelled as per section 41GK of the Act., effective 21/06/2024
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for GENTAMICIN NORIDEM gentamicin (as sulfate) 80 mg/2 mL solution for injection ampoule.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Interpharma Pty Ltd - D-mine Infusion Set - Electric infusion pump administration set.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for METRONIDAZOLE NORIDEM, metronidazole 500mg/100mL solution for injection bottle.
-
Cancellation or suspensionUnder subsection 41GA(1)(a) there is a potential risk of death, serious illness or serious injury if the kind of device continues to be included in the Register, effective 21/12/2023
-
Cancellation or suspensionUnder subsection 41GA(1)(a) there is a potential risk of death, serious illness or serious injury if the kind of device continues to be included in the Register, effective 21/12/2023
-
Prescription medicine decision summaryHeparin Interpharma (heparin sodium) is approved for prophylaxis and treatment of deep vein thrombosis in patients 18 years and older.